Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

11.3K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decoding disease and therapy through multiomics integration and systems analysis.

Briefings in bioinformatics·2026
Same author

Impaired Brain Growth in Children Perinatally Infected With Chikungunya.

Pediatric neurology·2026
Same author

Immunogenetic Variants in Major Mental and Neurodevelopmental Disorders.

Biological psychiatry·2026
Same author

The 12 o'clock assay: an optimized dodecaplex droplet digital PCR assay for robust DNA methylation quantification and epigenetic clock-based age-predictions.

Clinical epigenetics·2026
Same author

SCANDARE: an institutional dynamic prospective interventional biobanking study.

BMC cancer·2026
Same author

HaploExplore, a software specifically designed for the detection of minor allele (MiA-) haploblocks.

NAR genomics and bioinformatics·2025

Related Experiment Video

Updated: May 13, 2025

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
09:36

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA

Published on: April 10, 2018

25.1K

High tissue specificity of lncRNAs maximises the prediction of tissue of origin of circulating DNA.

Elyas Mouhou1, Fabien Genty2, Walid El M'selmi3

  • 1Laboratoire GBCM (EA7528), Conservatoire national des arts et métiers (CNAM), Paris, France.

Scientific Reports
|April 15, 2025
PubMed
Summary
This summary is machine-generated.

This study enhances circulating tumor DNA (ctDNA) detection by analyzing cell-free DNA (cfDNA) fragmentation patterns near transcription start sites. Long non-coding RNAs (lncRNAs) show superior tissue specificity, improving cancer diagnosis accuracy.

More Related Videos

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
05:27

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Published on: June 16, 2023

1.3K
RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level
11:04

RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level

Published on: May 19, 2019

9.8K

Related Experiment Videos

Last Updated: May 13, 2025

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
09:36

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA

Published on: April 10, 2018

25.1K
Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
05:27

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Published on: June 16, 2023

1.3K
RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level
11:04

RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level

Published on: May 19, 2019

9.8K

Area of Science:

  • Genomics
  • Biomarkers
  • Cancer Research

Background:

  • Plasma DNA sequencing holds promise for cancer diagnosis and monitoring.
  • Low concentrations of circulating tumor DNA (ctDNA) and underdeveloped statistical models present significant challenges.
  • Cell-free DNA (cfDNA) fragmentation patterns offer potential biomarkers.

Purpose of the Study:

  • To evaluate binary classification models using cfDNA fragmentation features around transcription start sites (TSSs).
  • To compare the utility of long non-coding RNA (lncRNA) genes versus coding genes for cancer detection.
  • To determine optimal gene class selection criteria for predictive models.

Main Methods:

  • Analysis of cfDNA fragmentation patterns around TSSs in healthy patient datasets.
  • Investigated fragment density, gene types (lncRNA vs. coding), and gene class selection criteria.
  • Developed and validated binary classification models for predictive accuracy.

Main Results:

  • The definition of tissue-specific gene classes significantly impacts model performance.
  • Long non-coding RNAs (lncRNAs) demonstrate higher tissue specificity compared to coding genes.
  • lncRNAs exhibit superior sensitivity and specificity in classifying samples.

Conclusions:

  • Optimizing gene class definitions is crucial for accurate cfDNA-based cancer detection.
  • lncRNA fragmentation patterns are highly promising biomarkers for sensitive and specific cancer diagnosis.
  • This approach advances the translational application of cfDNA sequencing in oncology.